In the News: Traceability system for drug distribution, China's two-child policy, and foreign shareholders

August 28, 2018 | BY

Jacelyn Johnson

China introduces a draft on regulating an information-based traceability system for drugs; family planning policies may be revised in proposed amendments to China's Civil Code, and new administrative measures for foreign shareholders in foreign-invested futures companies.

Information-based Traceability System for Drugs to be Regulated

China has jumped on the World Health Organization's bandwagon of implementing an information-based traceability regulation for drugs.

The State Drug Administration has recently drafted and issued the Guiding Opinions on Developing the Information-based Traceability System for Drugs. The “Draft for Comment” stipulates that drug marketing license holders shall provide downstream enterprises or medical institutions with relevant traceable information when selling drugs. Records and proof for traceable information of drugs shall be stored for at least five years after the expiration of the drugs.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]